Full-Time

Business Administrator

Confirmed live in the last 24 hours

Viatris

Viatris

10,001+ employees

Global healthcare company providing medicines access

No salary listed

Mid, Senior

Dublin, Ireland

Category
Project Management
Business & Strategy
Required Skills
Data Analysis
Requirements
  • Experience in project coordination within a large multinational organisation; preference for experience in pharmaceutical and/or medical device organisation.
  • Experience with complex and global projects in a large organisation; a minimum of 5 years’ experience.
  • Experience in tracking and coordinating project deliverables with external parties to enable timelines to be met.
  • Experience in internal or external communications on behalf of an organisation.
  • Ability to work in fast paced environment and respond effectively to rapidly changing business needs.
  • Excellent communicator: clear and concise in communications with External and Internal partners with the ability to work flexibly across a multi-disciplinary team achieving departmental goals and established timelines.
  • A team player: willing to support any other organisational needs/activities outside primary expertise to continuously enhance the Global Device Development group.
  • Positive can-do attitude with action that engages people and responds well to work requests from department colleagues in timely and accurate manner.
Responsibilities
  • Work across GDD in the development and continual improvement of Business Processes to enable efficient delivery day to day.
  • Support Head of Strategic Operations in projects, assignments, business, or project coordination, delivery, and reporting.
  • Perform data collection, analysis and reporting to manager with proposals for decision making purposes.
  • Assist in preparing and maintaining information related to GDD Business Process effectiveness and help identify potential efficiency improvement opportunities.
  • Coordinate and collate business presentations, department files and improvement initiatives.
  • Lead and coordinate the Recruitment Process for GDD, collaborating with Managers, and colleagues to land the best talent for GDD.
  • Build and grow relations as the GDD point of contact between Human Resources and Talent Acquisition (TA) team.
  • Assist TA in efficiently coordinating interviews to enable best candidate experience.
  • Responsible for coordination and management of the GDD Training Program, including external & internal training.
  • Lead and coordinate the onboarding of new colleagues through the GDD Onboarding Process such as new hire induction, planning & training.
  • Coordinate the GDD Offboarding process.
  • Logistical support and sample request coordination for Program Leads and Device Program Teams, working with external and internal stakeholders to request and ensure secure delivery to final location, as required.
  • Take responsibility for improvement initiatives and projects to enable delivery in line with GDD Business Goals, and Improvement Initiatives.
  • Develop templates and processes to enable consistent application and implementation of core business process delivery in GDD.
  • Ensure that communications/requests are responded to promptly and followed up, as appropriate.
  • Assist in scheduling calls and making travel arrangements.
  • Manage and disseminate communications such as newsletters, facilitate communication meetings or drafting presentations.
  • Responsible for development and issue of appropriate GDD Communications and GDD-TV content and publication.
  • Analyse and coordinate department activities to achieve established GDD goals.
  • Compilation and reporting of GDD metrics on a weekly, monthly, and quarterly basis.
  • Coordinate the GDD Headcount report to align with budgeted allocation.
  • Update and control GDD Org chart.
  • Support for GDD/Strategic Operations in preparation of reports and presentations.

Viatris provides a wide range of healthcare products that combine generic and brand-name medicines to meet global health needs. Their portfolio includes high-quality medications for various conditions, from acute illnesses to chronic diseases, ensuring that they can support patients at every stage of life. Viatris operates a global supply chain that allows them to deliver these medicines efficiently to approximately 1 billion patients worldwide. What sets Viatris apart from its competitors is its unique ability to bridge the gap between generics and brands, offering a diverse selection of medicines while maintaining a focus on accessibility. The company's goal is to empower people to live healthier lives by providing access to essential medications wherever and whenever they are needed.

Company Size

10,001+

Company Stage

IPO

Headquarters

Canonsburg, Pennsylvania

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Viatris can leverage digital health trends to expand telemedicine and remote monitoring services.
  • The rise of value-based healthcare aligns with Viatris' focus on patient outcomes and cost-effectiveness.
  • Expansion in emerging markets offers Viatris opportunities to increase market presence and reach.

What critics are saying

  • Increased competition from low-cost generics could erode Viatris' market share.
  • Patent expirations in 2025 may lead to revenue loss from generic competition.
  • Ongoing opioid litigation could result in financial liabilities and reputational damage.

What makes Viatris unique

  • Viatris bridges the gap between generics and brands, offering a unique healthcare approach.
  • The company has a diverse portfolio, supplying medicines to 1 billion patients annually.
  • Viatris' global supply chain is designed to reach patients worldwide efficiently.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Paid Holidays

Company News

PharmiWeb
May 7th, 2025
Viatris Announces Quarterly Dividend

PITTSBURGH, May 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on June 16, 2025, to shareholders of record as of the close of business on May 23, 2025.About ViatrisViatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris

PR Newswire
Mar 28th, 2025
Viatris To Report First Quarter 2025 Financial Results On May 8, 2025

PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Mar 5th, 2025
Viatris To Present At The Barclays 27Th Annual Global Healthcare Conference

PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Feb 27th, 2025
Viatris Maintains Dividend Policy For 2025 And Announces Quarterly Dividend

PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock. The dividend is payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025. This marks the fifth consecutive year the Company has paid a dividend.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally